论文部分内容阅读
[目的]观察神龙抗栓胶囊联合血栓通与西药治疗急性脑梗死疗效。[方法]使用随机平行对照方法,将60例住院患者按病志号抽签方法简单随机分为两组,抗血小板聚集、降脂、降压、降糖等对症治疗。对照组30例血栓通500mg+250mL生理盐水或葡萄糖,静滴,1次/d。治疗组30例神龙抗栓胶囊,0.9g/次,3籼d,口服;血栓通治疗同对照组。连续治疗14d为1疗程。观测临床症状、神经功能缺损评分、hs-CRP、不良反应。治疗1疗程,判定疗效。[结果]治疗组痊愈10例,显效13例,有效6例,无效1例,总有效率96.67%。对照组痊愈7例,显效8例,有效9例,无效6例,总有效率80.00%。治疗组疗效优于对照组(P<0.05)。神经功能缺损评分、hs-CRP两组均有改善(P<0.01),治疗组改善优于对照组(P<0.05)。[结论]神龙抗栓胶囊联合血栓通与西药治疗急性脑梗死,疗效满意,无严重不良反应,值得推广。
[Objective] To observe the curative effect of Shenlong Kangxian Capsule combined with Xuesaitong and western medicine in treating acute cerebral infarction. [Methods] Using randomized parallel control method, 60 inpatients were randomly divided into two groups according to the method of lottery of patients’ disease. Anti-platelet aggregation, lipid-lowering, antihypertensive, hypoglycemic and other symptomatic treatment were randomly divided into two groups. Control group, 30 cases of thrombus 500mg + 250mL saline or glucose, intravenous infusion, 1 time / d. 30 cases of the treatment group Shenlong antithrombotic capsules, 0.9g / times, 3 indications d, oral; Xueshuantong treatment with the control group. Continuous treatment 14d for a course of treatment. Observation of clinical symptoms, neurological deficit score, hs-CRP, adverse reactions. Treatment of a course of treatment to determine the efficacy. [Results] In the treatment group, 10 cases were cured, 13 cases were markedly effective, 6 cases were effective, 1 case was ineffective and the total effective rate was 96.67%. The control group cured 7 cases, 8 cases markedly effective in 9 cases, 6 cases were ineffective, the total effective rate was 80.00%. The treatment group was better than the control group (P <0.05). Neurological deficit scores, hs-CRP were improved in both groups (P <0.01), the treatment group improved better than the control group (P <0.05). [Conclusion] Shenlong Kangxie Capsule combined with Xuesaitong and western medicine in the treatment of acute cerebral infarction has satisfactory curative effect and no serious adverse reactions and is worth popularizing.